Ionic Ventures LLC 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Sale |
2024-09-30 | 13G | Vivos Therapeutics, Inc. VVOS |
Ionic Ventures LLC | 83,000 1.800% |
-329,064 (-79.86%) |
Filing |
| 2024-09-24 2:59 pm Purchase |
2024-09-19 | 13G | Vivos Therapeutics, Inc. VVOS |
Ionic Ventures LLC | 412,064 8.700% |
412,064 (New Position) |
Filing |